Title: Ebrotidine
CAS Registry Number: 100981-43-9
CAS Name: N-[[[2-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]ethyl]amino]methylene]-4-bromobenzenesulfonamide
Additional Names: N-p-bromobenzenesulfonyl-N¢-[2-[[[2-[(aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]ethyl]formamidine; p-bromo-N-[[[2-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]ethyl]amino]methylene]benzenesulfonamide
Manufacturers' Codes: FI-3542
Trademarks: Ebrocit (Ferrer); Ebrodin (Ferrer); Ulsanic (Ferrer)
Molecular Formula: C14H17BrN6O2S3
Molecular Weight: 477.42
Percent Composition: C 35.22%, H 3.59%, Br 16.74%, N 17.60%, O 6.70%, S 20.15%
Literature References: Histamine H2-receptor antagonist. Prepn: R. Foguet et al., EP 159012; eidem, US 4728655 (1985, 1988 both to Ferrer); L. Anglada et al., Eur. J. Med. Chem. 23, 97 (1988). Clinical pharmacology: S. J. Konturek et al., Scand. J. Gastroenterol. 27, 438 (1992); M. Maczka et al., J. Physiol. Pharmacol. 43, 139 (1992). Clinical evaluation in gastroesophageal reflux disease: E. Sito et al., ibid. 44, 259 (1993). HPLC determn in urine and metabolism study: E. Rozman et al., J. Pharm. Sci. 83, 252 (1994).
Properties: Crystals from ethyl acetate. mp 142.5-146°.
Melting point: mp 142.5-146°
Therap-Cat: Antiulcerative.
Keywords: Antiulcerative; Histamine H2-Receptor Antagonist. |